MarketCapExport financials
Dolby Laboratories (DLB)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Dolby Laboratories Balance Sheet 2025-2007 | DLB
Brief overview of Dolby Laboratories's balance sheet structure
The review uses the five latest available annual reports between 2020 and 2025.
Assets increased +10.6%, from $2.9 billion to $3.2 billion. The business expanded, but without sharp acceleration.
Liabilities expanded faster than the asset base, +24.4% versus +10.6%. Debt-service capacity deserves attention.
Internal capital represents 81.3% of the balance sheet, previously 83.4%. This is a strong capital position.
Negative net debt of -$663 million means cash holdings are larger than debt obligations.
Cash accounts for 21.7% of assets versus 36.7% initially. The change indicates the degree of financial flexibility.
Retained earnings stand at $2.6 billion; the five-period change was +7.9%. This reflects accumulated business performance.
Overall picture
Dolby Laboratories's balance sheet is broadly resilient, though selected areas require monitoring. The balance between assets, equity and liabilities remains the key issue.
Annual Balance Sheet Dolby Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-663 M | -435 M | -695 M | -569 M | -1.15 B | -991 M | -797 M | -918 M | -627 M | -516 M | -532 M | -568 M | -454 M | -469 M | -552 M | - | - | - | - |
Long Term Debt |
28.5 M | 34.8 M | 37 M | 37.7 M | 56.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
10.4 M | 12.2 M | 13.6 M | 13.3 M | 15.4 M | 15.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 212 M | 208 M | 216 M | 151 M | 118 M | 117 M | 84.6 M | 84 M | 83.7 M | 39.7 M | - | - | - | - |
Total Current Liabilities |
438 M | 418 M | 422 M | 278 M | 316 M | 267 M | 307 M | 272 M | 246 M | 213 M | 210 M | 189 M | 173 M | 157 M | 159 M | 166 M | 157 M | - | - |
Total Liabilities |
596 M | 623 M | 608 M | 439 M | 501 M | 479 M | 514 M | 501 M | 397 M | 331 M | 326 M | 274 M | 257 M | 240 M | 199 M | 217 M | 218 M | - | - |
Deferred Revenue |
31.4 M | 31.6 M | 31.5 M | 18.6 M | 18.5 M | 15.4 M | 20 M | 23.9 M | 23.2 M | 24.2 M | 18.9 M | - | 20.9 M | 23.5 M | 26.7 M | 9.65 M | 37.2 M | - | - |
Retained Earnings |
2.63 B | 2.5 B | 2.39 B | 2.3 B | 2.61 B | 2.44 B | 2.33 B | 2.31 B | 2.08 B | 1.94 B | 1.8 B | 1.66 B | 1.45 B | 1.71 B | 1.45 B | 1.14 B | 852 M | - | - |
Total Assets |
3.23 B | 3.11 B | 2.98 B | 2.69 B | 3.11 B | 2.92 B | 2.82 B | 2.87 B | 2.53 B | 2.31 B | 2.13 B | 1.98 B | 1.74 B | 1.96 B | 1.88 B | 1.71 B | 1.58 B | - | - |
Cash and Cash Equivalents |
702 M | 482 M | 745 M | 620 M | 1.23 B | 1.07 B | 797 M | 918 M | 627 M | 516 M | 532 M | 568 M | 454 M | 493 M | 552 M | 546 M | 452 M | 395 M | 368 M |
Book Value |
2.63 B | 2.49 B | 2.37 B | 2.25 B | 2.6 B | 2.44 B | 2.31 B | 2.36 B | 2.14 B | 1.98 B | 1.81 B | 1.71 B | 1.48 B | 1.72 B | 1.69 B | 1.49 B | 1.36 B | - | - |
Total Shareholders Equity |
2.62 B | 2.48 B | 2.36 B | 2.25 B | 2.6 B | 2.43 B | 2.31 B | 2.19 B | 2.14 B | 1.97 B | 1.81 B | 1.71 B | 1.48 B | 1.72 B | 1.66 B | 1.47 B | 1.34 B | 1.07 B | 819 M |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet Dolby Laboratories
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
37.6 M | 39.8 M | 39.8 M | 30.3 M | 28.2 M | 28.2 M | 29.7 M | 33 M | 35.6 M | 35.6 M | 37.7 M | - | 36.6 M | 36.6 M | - | 34.2 M | 37.7 M | 44.3 M | 48.2 M | 52.6 M | 56.7 M | 61 M | 56.7 M | 64.3 M | 65.3 M | 65.3 M | 65.3 M | 58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
564 M | 622 M | 622 M | 589 M | 582 M | 582 M | 646 M | 642 M | 526 M | 526 M | 607 M | - | 625 M | 625 M | - | 456 M | 439 M | 460 M | 458 M | 462 M | 501 M | 507 M | 501 M | 526 M | 479 M | 479 M | 479 M | 555 M | 509 M | 509 M | 509 M | 474 M | 495 M | 495 M | 492 M | 459 M | 390 M | 390 M | 390 M | 330 M | 331 M | 331 M | 331 M | - | 317 M | 317 M | 317 M | 271 M | 252 M | 252 M | 252 M | 216 M | 238 M | 238 M | 238 M | 206 M | 218 M | 218 M | 218 M | 195 M | 199 M | 199 M | 199 M | 230 M |
Deferred Revenue |
33.6 M | 38.8 M | 38.8 M | 37.1 M | 36 M | 36 M | 39.6 M | 37.1 M | 32.6 M | 32.6 M | 37.7 M | - | 36.6 M | 36.6 M | - | 22.4 M | 18.6 M | 21.2 M | 22.1 M | 21.4 M | 18.5 M | 18.2 M | 18.5 M | 21.2 M | 15.4 M | 15.4 M | 15.4 M | 19.8 M | 20 M | 20 M | 20 M | 19.6 M | 23.9 M | 21.4 M | 22.5 M | 23.4 M | 23.2 M | 23.2 M | 23.2 M | 24.4 M | 24.2 M | 24.2 M | 24.2 M | - | 18.9 M | 18.9 M | 18.9 M | 21.2 M | 12.5 M | 12.5 M | 12.5 M | 15.2 M | 20.9 M | 20.9 M | 20.9 M | 22.7 M | 23.5 M | 23.5 M | 23.5 M | 24.4 M | 26.7 M | 26.7 M | 26.7 M | 12 M |
Retained Earnings |
2.6 B | 2.63 B | 2.63 B | 2.6 B | 2.62 B | 2.62 B | 2.6 B | 2.54 B | 2.46 B | 2.46 B | 2.45 B | - | 2.4 B | 2.4 B | - | 2.32 B | 2.3 B | 2.48 B | 2.62 B | 2.65 B | 2.61 B | 2.63 B | 2.61 B | 2.57 B | 2.44 B | 2.44 B | 2.44 B | 2.35 B | 2.33 B | 2.33 B | 2.33 B | 2.36 B | 2.31 B | 2.31 B | 2.31 B | 1.99 B | 2.08 B | 2.08 B | 2.08 B | 1.98 B | 1.94 B | 1.94 B | 1.94 B | - | 1.8 B | 1.8 B | 1.8 B | 1.69 B | 1.66 B | 1.66 B | 1.66 B | 1.5 B | 1.45 B | 1.45 B | 1.45 B | 1.32 B | 1.71 B | 1.71 B | 1.71 B | 1.52 B | 1.45 B | 1.45 B | 1.45 B | 1.07 B |
Total Assets |
3.16 B | 3.25 B | 3.25 B | 3.19 B | 3.2 B | 3.2 B | 3.23 B | 3.16 B | 2.97 B | 2.97 B | 3.04 B | - | 3.01 B | 3.01 B | - | 2.75 B | 2.69 B | 2.92 B | 3.06 B | 3.1 B | 3.11 B | 3.14 B | 3.11 B | 3.1 B | 2.92 B | 2.92 B | 2.92 B | 2.89 B | 2.82 B | 2.82 B | 2.82 B | 2.82 B | 2.87 B | 2.87 B | 2.86 B | 2.51 B | 2.53 B | 2.53 B | 2.53 B | 2.33 B | 2.31 B | 2.31 B | 2.31 B | - | 2.13 B | 2.13 B | 2.13 B | 2.02 B | 1.98 B | 1.98 B | 1.98 B | 1.77 B | 1.74 B | 1.74 B | 1.74 B | 1.55 B | 1.96 B | 1.96 B | 1.96 B | 1.94 B | 1.88 B | 1.88 B | 1.88 B | 1.7 B |
Cash and Cash Equivalents |
669 M | 594 M | 594 M | 644 M | 699 M | 699 M | 750 M | 612 M | 742 M | 779 M | 824 M | 709 M | 765 M | 799 M | 693 M | 626 M | 620 M | 867 M | 900 M | 1.06 B | 1.23 B | 1.23 B | 1.23 B | 1.11 B | 1.08 B | 1.07 B | 1.07 B | 741 M | 797 M | 797 M | 797 M | 791 M | 918 M | 918 M | 918 M | 596 M | 634 M | 627 M | 627 M | 513 M | 520 M | 516 M | 513 M | - | 532 M | 532 M | 532 M | 409 M | 568 M | 568 M | 409 M | 485 M | 454 M | 454 M | 485 M | 316 M | 493 M | 493 M | 316 M | 654 M | 552 M | 552 M | 654 M | 519 M |
Book Value |
2.59 B | 2.63 B | 2.63 B | 2.6 B | 2.61 B | 2.61 B | 2.58 B | 2.52 B | 2.45 B | 2.45 B | 2.44 B | - | 2.38 B | 2.38 B | - | 2.29 B | 2.25 B | 2.46 B | 2.61 B | 2.64 B | 2.6 B | 2.63 B | 2.6 B | 2.57 B | 2.44 B | 2.44 B | 2.44 B | 2.34 B | 2.31 B | 2.31 B | 2.31 B | 2.35 B | 2.37 B | 2.37 B | 2.37 B | 2.06 B | 2.14 B | 2.14 B | 2.14 B | 2 B | 1.98 B | 1.98 B | 1.98 B | - | 1.82 B | 1.82 B | 1.82 B | 1.75 B | 1.73 B | 1.73 B | 1.73 B | 1.55 B | 1.5 B | 1.5 B | 1.5 B | 1.35 B | 1.74 B | 1.74 B | 1.74 B | 1.74 B | 1.69 B | 1.69 B | 1.69 B | 1.47 B |
Total Shareholders Equity |
2.58 B | 2.62 B | 2.62 B | 2.59 B | 2.6 B | 2.6 B | 2.58 B | 2.52 B | 2.43 B | 2.45 B | 2.44 B | 2.36 B | 2.37 B | 2.38 B | 2.36 B | 2.29 B | 2.25 B | 2.46 B | 2.61 B | 2.64 B | 2.6 B | 2.63 B | 2.59 B | 2.57 B | 2.44 B | 2.43 B | 2.43 B | 2.33 B | 2.31 B | 2.31 B | 2.31 B | 2.34 B | 2.36 B | 2.36 B | 2.36 B | 2.05 B | 2.14 B | 2.14 B | 2.14 B | 1.99 B | 1.97 B | 1.97 B | 1.97 B | - | 1.81 B | 1.81 B | 1.81 B | 1.74 B | 1.71 B | 1.71 B | 1.71 B | 1.53 B | 1.48 B | 1.48 B | 1.48 B | 1.33 B | 1.72 B | 1.72 B | 1.72 B | 1.72 B | 1.66 B | 1.66 B | 1.66 B | 1.45 B |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of Dolby Laboratories, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Russia
Britain
Canada
China
